WHEN $$$ IS MORE IMPORTANT THAN HUMAN LIVES
The congressional report focused on Clinton’s relationship with Indian drug manufacturer Ranbaxy which pleaded guilty in 2013 to 7 counts of fraud and introduction of adulterated drugs into interstate commerce. The most troubling revelations concern the Clinton Foundation’s promotion of Ranbaxy despite evidence the Indian firm had poor quality control and attempted to cover it up through fraudulent reporting to the FDA. The FDA sent a public warning letter to Ranbaxy in 2006 about irregularities in the company’s quality control efforts.
The study also examined how the program benefited the Clinton Foundation in terms of donor contributions. Clinton co-founded the American Indian Foundation with businessmen Rajat Gupta and Vinod Gupta in 2001. Rajat was convicted of insider trading in 2012. Vinod was forced to resign as CEO and chairman of InfoGroup and fined $9 million in an SEC investigation. One of the charges against Vinod stated he awarded Bill Clinton $3.3 million without board approval.
Although Ranbaxy’s generic drugs are now barred from being sold in the U.S., Bill Clinton continues to praise Ranbaxy and the Clinton Initiative still distributes the company’s HIV/AID drugs to patients abroad.
The congressional study suggests President Clinton relaxed quality standards in a 2000 executive order that “relaxed intellectual property policy standards,” promising the U.S. government “would not revoke or revise the intellectual property laws of any ‘Sub-Saharan country’ relating to HIV/AIDS medicines or technologies,” the report states.
VOTE TRUMP 2016.